Cytogenetic alterations in prostate cancer;Zytogenetische veranderungen des prostatakarzinoms

Pathologe

Volumn 19, Issue 1, 1998, Pages 63-68

  Sauter, G ^a,b   Bubendorf, L ^a   Moch, H ^a   Gasser, Th C ^a   Mihatsch, M J ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Cytogenetics; Gene amplification; Polysomy; Prostate cancer

Indexed keywords

CHROMOSOME 11Q; CHROMOSOME 7; CHROMOSOME 8Q; CHROMOSOME DELETION; CYTOGENETICS; GENE AMPLIFICATION; HUMAN; ONCOGENE; POLYSOME; PROSTATE CANCER; REVIEW; TUMOR SUPPRESSOR GENE; Y CHROMOSOME; CHROMOSOME ABERRATION; CHROMOSOME MAP; GENE EXPRESSION REGULATION; GENETICS; MALE; NEOPLASM; PATHOLOGY; PHYSIOLOGY; PROGNOSIS; PROSTATE; PROSTATE TUMOR;

ANDROGEN RECEPTOR; DNA; TUMOR MARKER;

CHROMOSOME ABERRATIONS; CHROMOSOME DELETION; CHROMOSOME MAPPING; DNA, NEOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; NEOPLASMS, HORMONE-DEPENDENT; PROGNOSIS; PROSTATE; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; TUMOR MARKERS, BIOLOGICAL;

EID: 0031934693     PISSN: 01728113     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002920050256     Document Type: Review

References (48)

1. Adolfsson J (1994) Prognostic value of desoxyribonucleic acid content in prostate cancer: a review of current results. Int J Cancer 58:211-216
2. Alcaraz A, Takahashi S, Brown JA, Herath JF, Bergstralh EJ, Larson KJ, Lieber MM, Jenkins RB (1994) Aneuploidy and aneusomy of chromosome 7 detected by fluorescence in situ hybridization are markers of poor prognosis in prostate cancer. Cancer Res 54:3998-4002
3. Alers JC, Krijtenburg PJ, Vissers KJ, Bosman FT, van der Kwast T, van Dekken H (1995) Interphase cytogenetics of prostatic adenocarcinoma and precursor lesions: analysis of 25 radical prostatectomies and 17 adjacent prostatic intraepithelial neoplasias. Genes Chromosom Cancer 12:241-250
4. Aly MS, Cin PD, Van dVW, van PH, Ameye F, Baert L, Van dBH (1994) Chromosome abnormalities in benign prostatic hyperplasia. Genes Chromosom Cancer 9:277-233
5. Arps S, Rodewald A, Schmalenberger B, Carl P, Bressel M, Kastendieck H (1993) Cytogenetic survey of 32 cancers of the prostate. Cancer Genet Cytogenet 66:93-99
6. Bandyk MG, Zhao L, Troncoso P, Pisters LL, Palmer JL, von EA, Chung LW, Liang JC (1994) Trisomy 7: a potential cytogenetic marker of human prostate cancer progression. Genes Chromosom Cancer 9:19-27
7. Baretton GB, Valina C, Vogt T, Schneiderbanger K, Diebold J, Lohrs U (1994) Interphase cytogenetic analysis of prostatic carcinomas by use of nonisotopic in situ hybridization. Cancer Res 54:4472-4480
8. Casalone R, Granata CP, Minelli E, Portentoso P, Righi R, Meroni E, Giudici A, Donati D, Riva C, Salvatore S et al. (1992) Significance of the clonal and sporadic chromosome abnormalities in non-neoplastic renal tissue. Hum Genet 90:71-78
9. Cher ML, Bova GS, Moore DH, Small EJ, Carroll PR, Pin SS, Epstein JI, Isaacs WB, Jensen RH (1996) Genetic alterations in untreated metastases and androgen-independent prostate cancer detected by comparative genomic hybridization and allelotyping. Cancer Res 56:3091-3102
10. Cher ML, Ito T, Weidner N, Caroll PR, Jensen RH (1995) Mapping of regions of physical deletion on chromosome 16q in prostate cancer cells by fluorescence in situ hybridization (FISH). J Urol 153:249-254
11. Cher ML, MacGrogan D, Bookstein R, Brown JA, Jenkins RB, Jensen RH (1994) Comparative genomic hybridization, allelic imbalance, and fluorescence in situ hybridization on chromosome 8 in prostate cancer. Genes Chromosom Cancer 11:153-162
12. Eagle LR, Yin X, Brothman AR, Williams BJ, Atkin NB, Prochownik EV (1995) Mutation of the MXI1 gene in prostate cancer. Nat Genet 9:249-255
13. Elfving P, Cigudosa JC, Lundgren R, Limon J, Mandahl N, Kristoffersson U, Heim S, Mitelman F (1990) Trisomy 7, trisomy 10, and loss of the Y chromosome in short-term cultures of normal kidney tissue. Cytogenet Cell Genet 53:123-125
14. Emmert BM, Vocke CD, Pozzatti RO, Duray PH, Jennings SB, Florence CD, Zhuang Z, Bostwick DG, Liotta LA, Linehan WM (1995) Allelic loss on chromosome 8p12-21 in microdissected prostatic intraepithelial neoptasia. Cancer Res 55:2959-2962
15. Fujiwara Y, Emi M, Ohata H, Kato Y, Nakajima T, Mori T, Nakamura Y (1993) Evidence for the presence of two tumor suppressor genes on chromosome 8p for colorectal carcinoma. Cancer Res 53:1172-1174
16. Hopman A, Ramaekers F, Raap A, Beck J, Devilee P, van der Ploeg M, Vooijs G (1988) In situ hybridization as a tool to study numerical chromosome aberrations in solid bladder tumors. Histochemistry 89:307-316
17. Johansson B, Heim S, Mandahl N, Mertens F, Mitelman F (1993) Trisomy 7 in nonneoplastic cells. Genes Chrom Cancer 6:199-205
18. Joos S, Bergerheim US, Pan Y, Matsuyama H, Bentz M, du Manoir S, Lichter P (1995) Mapping of chromosomal gains and losses in prostate cancer by comparative genomic hybridization. Genes Chromosomes Cancer 14:267-276
19. Kallioniemi A, Kallioniemi O, Sudar D, Rutovitz D, Gray J, Waldman F, Pinkel D (1992) Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 258:818-821
20. Kallioniemi A, Kallioniemi OP, Piper J, Tanner M, Stokke T, Chen L, Smith HS, Pinkel D, Gray JW, Waldman FM (1994) Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization. Proc Natl Acad Sci USA 91:2156-2160
21. Kallioniemi O, Kallioniemi A, Kurisu W, Thor A, Chen L, Smith H, Waldman F, Pinkel D, Gray J (1992) C-erbB-2 oncogene amplification in breast cancer analyzed by fluorescence in situ hybridization. Proc Natl Acad Sci USA 89:5321-5325
22. Kiang D, Frenning D, Goldman A, Ascensao V, Kennedy B (1978) Estrogen receptors and responses to chemotherapy and hormonal therapy in advanced breast cancer. N Engl J Med 299:1330
23. Konig JJ, Teubel W, van DJ, Romijn JC, Hagemeijer A, Schroder FH (1994) Loss and gain of chromosomes 1, 18, and Y in prostate cancer. Prostate 25:281-291
24. Latil A, Baron JC, Cussenot O, Fournier G, Boccon GL, Le DA, Lidereau R (1994) Oncogene amplifications in early-stage human prostate carcinomas. Int J Cancer 59:637-638
25. Latil A, Cussenot O, Fournier G, Driouch K, Lidereau R (1997) Loss of heterozygosity at chromosome 16p in prostate adenocarcinoma: identification of three independent regions. Cancer Res 57:1058-1062
26. Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang SI, Puc J, Miliaresis C, Rodgers L, McCombie R, Bigner SH, Giovanella BC, Ittmann M, Tycko B, Hibshoosh H, Wigler MH, Parsons R (1997) PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275:1943-1947
27. Liaw D, Marsh DJ, Li J, Dahia PL, Wang SI, Zheng Z, Bose S, Call KM, Tsou HC, Peacocke M, Eng C, Parsons R (1997) Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat Genet 16 64-67
28. Lieber MM, Murtaugh PA, Farrow GM, Myers RP, Blute ML (1995) DNA ploidy in surgically treated prostate cancer. Cancer 75:1935-1943
29. Limon J, Lundgren R, Elfving P, Heim S, Kristoffersson U, Mandahl N, Mitelman F (1989) Double minutes in two primary adenocarcinomas of the prostate. Cancer Genet Cytogenet 39:191-194
30. Macoska JA, Trybus TM, Sakr WA, Wolf MC, Benson PD, Powell IJ, Pontes JE (1994) Fluorescence in situ hybridization analysis of 8p allelic loss and chromosome 8 instability in human prostate cancer. Cancer Res 54:3824-3830
31. Mitelman F (1994) Catalog of chromosome aberrations in cancer. Wiley-Liss, New York
32. Pullman W, Bodmer W (1992) Cloning and characterization of a gene that regulates cell adhesion. Nature 356:529
33. Richter J, Jiang F, Görog J, Sartorius G, Moch H, Egenter C, Gasser T, Mihatsch M, Sauter G (1997) Marked genetic differences between pTa and pT1 papillary bladder cancer detected by comparative genomic hybridization. Cancer Res 57:2860-2864
34. Sauter G, Carooll P, Moch H, Kallioniemi A, Kurschmann R, Narayam P, Mihatsch M, Waldman F (1995) Increased c-myc gene copy number in advanced bladder cancer. Am J Pathol 146:1131-1139
35. Sauter G, Gasser T, Moch H, Richter J, Jiang F, Albrecht R, Novotny H, Wagner U, Bubendorf L, Mihatsch M (1997) DNA aberrations in urinary bladder cancer detected by flow cytometry and FISH. Urol Res 25:37-44
36. Sauter G, Moch H, Wagner U, Novotna H, Gasser T, Mattarelli G, Mihatsch M, Waldman F (1995) Y Chromosome loss detected by FISH in bladder cancer. Cancer Gen Cytogenet 82:163-169
37. Schröck E, Du Manoir S, Veldman T, Schoell B, Wienberg J, Ferguson-Smith M, Ning Y, Ledbetter D,Bar-Am I, Soenksen D, Garini Y, Ried T (1996) Multicolor spectral karyotyping of human chromosomes. Science 273 494-497
38. Shankey TV, Kallionemi OP, Koslowski JM, Lieber ML, Mayall BH, Miller G, Smith GJ (1993) Consensus review of the clinical utility of DNA content cytometry in prostate cancer. Cytometry 14:497-500
39. Smith JR, Freije D, Carpten JD, Gronberg H, Xu J, Isaacs SD, Brownstein MJ, Bova GS, Guo H, Bujnovszky P, Nusskern DR, Damber JE, Bergh A, Emanuelsson M, Kallioniemi OP, Walker Daniels J, Bailey Wilson JE, Beaty TH, Meyers DA, Walsn PC, Collins FS, Trent JM, Isaacs WB (1996) Major susceptibility locus for prostate cancer on chromosome 1 suggested by a genome-wide search. Science 274:1371-1374
40. Suzuki H, Emi M, Komiya A, Fujiwara Y, Yatani R, Nakamura Y, Shimazaki J (1995) Localization of a tumor suppressor gene associated with progression of human prostate cancer within a 1.2 Mb region of 8p22-p21.3. Genes Chromosomes Cancer 13:168-174
41. Takahashi S, Shan AL, Ritland SR, Delacey KA, Bostwick DG, Lieber MM, Thibodeau SN, Jenkins RB (1995) Frequent loss of heterozygosity at 7q31.1 in primary prostate cancer is associated with tumor aggressiveness of progression. Cancer Res 55:4114-4119
42. Trapman J, Sleddens HF, van dWM, Dinjens WN, Konig JJ, Schroder FH, Faber PW, Bosman FT (1994) Loss of heterozygosity of chromosome 8 microsatellite loci implicates a candidate tumor suppressor gene between the loci D8S87 and D8S133 in human prostate cancer. Cancer Res 54:6061-6064
43. Umbas R, Isaacs WB, Bringuier PP, Schaafsma HE, Karthaus HF, Osterhof GON, Debruyne FM, Schalken JA (1994) Decreased E-Cadherin expression is associated with poor prognosis in patients with prostate cancer. Cancer Res 54:3929-3933
44. United Kingdom Cancer Cytogenetics Group (1992) Loss of the Y chromosome from normal and neoplastic bone marrows. Genes Chromosom Cancer 5:83-88
45. Van Dekken H, Alers J (1993) Loss of chromosome Y in prostate cancer, but not in stromal tissue. Cancer Genet Cytogenet 66:131-132
46. Visakorpi T, Hyytinen E, Koivisto P, Tanner M, Kemanen R, Palmberg C, Palotie A, Tammela T, Isola J, Kallioniemi OP (1995) In vivo amplification of the androgen receptor gene and progression of human prostate cancer. Nat Genet 9:401-406
47. Visakorpi T, Kallioniemi AH, Syvanen AC, Hyytinen ER, Karhu R, Tammela T, Isola JJ, Kallioniemi OP (1995) Genetic changes in primary and recurrent prostate cancer by comparative genomic hybridization. Cancer Res 55:342-347
48. Zenklusen JC, Thompson JC, Troncoso P, Kagan J, Conti CJ (1994) Loss of heterozygosity in human primary prostate carcinomas, a possible tumor suppressor gene at 7q31.1. Cancer Res 54:6370-6373